Petrol, diesel may be brought under GST in future: Goyal

Bengaluru, Apr 6: The Covid-19 Task Force aims to conduct 80,000 throat swab and blood tests over the next three weeks here.

According to Task Force Nodal Officer C N Manjunath an order for one lakh anti-body test kits has been placed, and was expected to arrive on April 12.

"From January 20 to March 23, more than 1.2 lakh people arrived at international airports from abroad. Of these, we have kept 37,358 under observation. The Health officials and personnel in fever clinics and hospitals are being trained to conduct the tests. There is no necessity to obtain a clearance to test people with suspected infection. Only laboratories need to get permission to test their blood and throat swab samples."

Bengaluru, Jun 15: After a three-month delay, seven-time MLA and former state minister DK Shivakumar, who has been appointed as the Karnataka Pradesh Congress Committee (KPCC) president, will take charge on July 2 at a simple function at the new party office here.

Mr Shivakumar was appointed as KPCC president on March 11.

Party sources said on Monday that Shivakumar plans to take charge of the party through a “pratijna dina” (pledge day) ceremony that would be telecast live to 7,800 locations across the state and over 10 lakh party workers are expected to attend it virtually.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.